Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | FASN | P49327 | 3/20 | 0.42 |
| ▸ | TLR4 | O00206 | 1/20 | 0.39 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.39 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 2/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | BTK | Q06187 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ALPL | P05186 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25018434 | 1.00 | EPHX1 (0.50) | EPHX1EPHX2ATMALDH1A1KDM4E | |
| SCHEMBL14805905 | 1.00 | EPHX1 (0.50) | EPHX1EPHX2ATMALDH1A1KDM4E | |
| SCHEMBL25018437 | 1.00 | EPHX1 (0.50) | EPHX1EPHX2ATMALDH1A1KDM4E | |
| SCHEMBL12384644 | 0.89 | ALDH1A1 (0.49) | EPHX1EPHX2ATMALDH1A1KDM4E | |
| SCHEMBL25689877 | 0.88 | EPHX1 (0.63) | EPHX1EPHX2ATMALDH1A1KDM4E | |
| SCHEMBL1176981 | 0.88 | EPHX1 (0.63) | EPHX1EPHX2ATMALDH1A1KDM4E | |
| SCHEMBL26513180 | 0.86 | ATM (0.44) | EPHX1EPHX2ATMALDH1A1KDM4E | |
| SCHEMBL25018678 | 0.85 | ATM (0.50) | EPHX1EPHX2ATMALDH1A1KDM4E | |
| SCHEMBL12422036 | 0.85 | ATM (0.50) | EPHX1EPHX2ATMALDH1A1KDM4E | |
| SCHEMBL25018770 | 0.81 | EPHX1 (0.66) | EPHX1EPHX2ATMALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230322792-A1 | CDK9 INHIBITORS | BAERENKRAFT THERAPEUTICS, LLC | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322792-A1 | CDK9 INHIBITORS | CDK9, CDK19, CDK3 | EPHX1 3487/4885EPHX2 3354/4885ATM 714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.